At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Perlane and Perlane-Ldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind Study Comparing Safety and Tolerability of Perlane® With and Without Addition of 0.3% Lidocaine HCL During Correction of Nasolabial Folds
In Brief
A clinical study evaluating Perlane and Perlane-L for Nasolabial Folds. Completed, enrolled 60 participants across 3 sites.
Detailed Summary
Safety study that compares Perlane to Perlane with Lidocaine while correcting wrinkles in the area around your nose.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasolabial Folds
CountriesUnited States
CollaboratorsQ-Med Scandinavia, Inc.
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
First PostedJan 2009
Primary CompletionMar 2009
Study CompletionApr 2009
TodayJul 2026
First PostedJan 15, 2009
Enrollment StartJan 1, 2009
Primary CompletionMar 1, 2009
Study CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 17.5 years ago
Interventions
Perlane and Perlane-Ldevice
This is a split face design and each subject received both Perlane-L and Perlane. Treatments were blinded, randomized, and successive.